Petros Pharmaceuticals Awards 7.25 Million RSUs to Board and Executives
I'm PortAI, I can summarize articles.
Petros Pharmaceuticals Inc. has awarded 7.25 million restricted stock units (RSUs) to its board and executives, effective January 2, 2026. Chairman Joshua Silverman will receive 4,375,000 RSUs, director Bruce Bernstein 1,875,000 RSUs, President Fady Boctor 500,000 RSUs, and director Wayne Walker 500,000 RSUs. Half of each grant vests immediately, with the remainder vesting six months later, contingent on continued service. These RSUs were issued outside the company’s 2020 Omnibus Incentive Compensation Plan.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments